Regulatory Expertise Target opportunity: pharmaceutical manufacturers or biotech firms seeking global regulatory affairs, eCTD submissions, and sponsor/FDA meeting management. B&H’s proven track record since 1988 and full electronic submission capabilities position them as a preferred regulatory partner for pre- and post-marketing activities.

Small Firm Flex Opportunity focus: leverage B&H’s small team size (2-10 employees) as a selling point for agile, personalized service in complex regulatory projects where large consultancies may introduce rigidity or higher costs.

Global Submissions Cross-border expansion: emphasize capabilities in global eCTD submissions and regulatory affairs support that appeal to midsize to large health sciences players seeking streamlined international filings and harmonized documentation.

Industry Fit Market entry: align with pharma manufacturing clients needing specialized CM&C technical writing and regulatory strategy to expedite filings, reduce cycle times, and improve sponsor-FDA interactions for meetings and milestones.

Financial Leverage Growth angle: with revenue in the 10–25M range, position B&H as a cost-effective alternative to large firms for targeted, high-value regulatory projects, offering competitive engagement models and faster onboarding for new clients.